Dr. Anthony D. Piscopio is a biotech entrepreneur and executive with over 35 years of leadership in life sciences. After earning his Ph.D. at the University of Wisconsin-Madison and completing an NIH-funded postdoctoral fellowship at The Scripps Research Institute, he launched his career as a Medicinal Chemist at Pfizer, specializing in small-molecule drug discovery. He played a key role in establishing Amgen’s small-molecule platform before co-founding Array BioPharma, where he spent over a decade as VP of Chemistry, shaping it into an industry leader. He later co-founded and led Chemizon, guiding it to a successful acquisition. Dr. Piscopio then co-founded OnKure, a precision medicine oncology company, serving as President and CEO for 13 years and advancing transformative cancer therapies. Today, he is Co-founder, President, and Board Chairman of BoCo Bio, an oncology-focused biotech company dedicated to breakthrough cancer treatments.

Dr. Robichaud, is currently a partner at Cure Ventures, a venture capital firm focusing on company formation around groundbreaking curative technologies. Most recently, he was the founding scientist and Chief Scientific Officer at Sage Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening, rare CNS disorders, where he led the discovery and development of two commercially approved drugs, Zulresso (2019) and Zurzuvae (2023) as well as 9 additional development candidates at Sage.  Dr. Robichaud is also the primary discovery scientist, and principal inventor of Caplyta (2109), an approved drug for the treatment of bipolar I and bipolar II depression (developed at DuPont, BMS, and Intracellular Therapeutics).  shad a brilliant and successful career .  Dr. Robichaud had a brilliant and successful career in senior executive leadership roles at Lundbeck USA, and Wyeth Research, Merck, DuPont and BMS.  Dr. Robichaud earned a B.S. in Chemistry from Rensselaer Polytechnic Institute, a Ph.D. in organic chemistry from the University of California, Irvine with Prof Larry E. Overman and was an American Chemical Society Postdoctoral Fellow at Colorado State University in the labs of Professor Albert I. Meyers.   Dr. Robichaud has coauthored more than 200 manuscripts and abstracts and is a co-inventor on >100 patents and patent applications.